I’ve been adding to my holdings this week as well. If you view...

I’ve been adding to my holdings this week as well. If you view the 3-5 year chart, we are still holding in the uptrend following covid. The results have been as expected, it’s the underlying which is important, as there is a clear end to the Ovato integration costs. If the SP holds around this level, we should still be in the uptrend, with P/E of around 6 on an underlying basis, this is well below the long term average. If management feel they are comfortable to provide FY24 guidance, then I feel this is a relatively safe bet at this price.

In addition to this, the current SP is at the lower end of what the company was at worth pre-covid when NPAT was around $34M. Today, IVE’s main competitor has now been swallowed, and we are looking at close to 50% higher normalised profits with minimal additional shares added to the register. I personally see a lot of value in todays price.